December 01, 2010

The Clinical Practice Guide­lines in Oncology for Breast Cancer, published by NCCN, have been updated to affirm the existing recommendation regarding the use of bevacizumab (Avastin) for the treatment of metastatic breast cancer.

Lung cancer patients with a specific genetic abnormality may benefit from a new treatment drug that targets tumors, according to a study published in the New England Journal of Medicine.

Aspirin and/or NSAID use may improve risk of high-grade prostate cancer

Patients with prostate cancer who use anticoagulants that include aspirin can reduce their disease-specific mortality by almost 60%, according to a study to be presented at the upcoming ASTRO meeting.